Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jeferson
Contact Jeferson, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
A Validated UPLC‐MS/MS Method for Monitoring Temozolomide and Perillyl Alcohol Metabolites in Biological Matrices: Insights From a Preclinical Pharmacokinetic Study
1 Introduction Malignant brain tumors represent one of the most challenging classes of cancer to treat due to limited accessibility to brain tissues, high mortality rates, and a lack of effective therapeutic options. Among these, glioblastoma is the most aggressive and lethal form, classified as a Grade IV tumor by the World Health Organization (WHO). It is histologically characterized by endothelial proliferation, cerebral necrosis, and an elevated metastatic potential (Louis et al. 2021).
Development and Characterization of Zein/Eudragit Composite Nanoparticles for Insulin Intranasal Delivery
1. Introduction Click to copy section linkSection link copied! The daily administration of insulin remains the primary therapy for patients with Type 1 Diabetes Mellitus (T1DM). (1) Parenteral injection continues to be the most commonly employed route of insulin delivery, despite its associated limitations, including patient discomfort due to needle use, reduced treatment adherence, and peripheral hyperinsulinemia, which can exacerbate insulin resistance in muscle and peripheral tissues.
Pharmaceutics | Free Full-Text | Oral Delivery of Liraglutide-Loaded Zein/Eudragit-Chitosan Nanoparticles Provides Pharmacokinetic and Glycemic Outcomes Comparable to Its Subcutaneous Injection in Rats
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jeferson
Contact Jeferson, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack